Impairment of brainstem implicit learning paradigms differentiates multiple system atrophy (MSA) from idiopathic Parkinson syndrome. Issue 9 (13th September 2013)

• Record Type: Journal Article
• Authors: von Lewinski, Friederike; Schwan, Michaela; Paulus, Walter; Trenkwalder, Claudia; Sommer, Martin
• Is Part Of: BMJ open. Volume 3:Issue 9(2013)
• Publication Date: 2013-09-13
• Subjects: Parkinsons disease -- Learning; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2013-003098
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Objectives: Learning as measured by eyeblink classical conditioning is preserved in patients with idiopathic Parkinson's disease, but severely affected in patients with progressive supranuclear palsy. We here sought to clarify whether procedural learning is impaired in multiple system atrophy (MSA), and whether it may be helpful for the differentiation of parkinsonian syndromes. Design: We investigated learning using (1) eyeblink classical conditioning with a delay (interstimulus interval 0 ms) and a trace (600 ms) paradigm and (2) a serial reaction time task. Setting: Participants were recruited from academic research centres. Participants: 11 patients with MSA and 11 healthy controls. Results: Implicit learning in eyeblink classical conditioning (acquisition of conditioned responses) as well as the serial reaction time task measures of implicit learning (reaction time change) are impaired in patients with MSA as compared with controls, whereas explicit learning as measured by the sequence recall of the serial reaction time task is relatively preserved. Analysis: We hypothesise that the learning deficits of patients with MSA are due to lesions of cerebellar and connected brainstem areas. Conclusions: A retrospective synopsis of these novel data on patients with MSA and groups of patients with idiopathic Parkinson's disease and progressive supranuclear palsy studied earlier suggest that eyeblink classical conditioning may contribute to the early differentiation of atypical Parkinson syndromes from idiopathic Parkinson's disease. This hypothesis should be tested in a prospective trial.